Osteoporosis y riesgo de fracturas en mujeres posmenopáusicas. Revisión bibliográfica
Palabras clave:
osteoporosis, posmenopáusicas, factores de riesgo
Resumen
En el presente estudio se estudia la Osteoporosis y riesgo de fracturas en mujeres posmenopáusicas. La prevalencia de la osteoporosis en mujeres posmenopáusicas es preocupante, ya que se asocia con una significativa morbilidad y mortalidad; siendo las fracturas de cadera las que presentan mayor impacto en la calidad de vida. El Objetivo general es describir a la osteoporosis y su relación con el riesgo de fracturas en mujeres posmenopáusicas mediante una revisión bibliográfica para mejorar su calidad de vida en la Atención Primaria de Salud. El proyecto se encuentra elaborado bajo un modelo de investigación positivista con un enfoque cualitativo de tipo básico bajo un diseño no experimental, de modalidad documental y metodología interpretativa. De los artículos analizados en este estudio se destacan una relación significativa entre la osteoporosis y la posmenopausia, atribuyendo este vínculo principalmente a los cambios hormonales asociados con esta etapa de la vida.
Descargas
La descarga de datos todavía no está disponible.
Citas
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. del C., & López-Ruiz, E. (2022). Current Status of the Diagnosis and Management of Osteoporosis. International Journal of Molecular Sciences, 23(16), 9465.
https://doi.org/10.3390/IJMS23169465
Amin, U., McPartland, A., O’Sullivan, M., & Silke, C. (2023). An overview of the management of osteoporosis in the aging female population. Women’s health (London, England), 19.
https://doi.org/10.1177/17455057231176655
Arceo-Mendoza, R. M., & Camacho, P. M. (2021a). Postmenopausal Osteoporosis: Latest Guidelines. Endocrinology and metabolism clinics of North America, 50(2), 167-178.
https://doi.org/10.1016/J.ECL.2021.03.009
Arceo-Mendoza, R. M., & Camacho, P. M. (2021b). Postmenopausal Osteoporosis: Latest Guidelines. Endocrinology and metabolism clinics of North America, 50(2), 167-178.
https://doi.org/10.1016/J.ECL.2021.03.009
Barron, R. L., Oster, G., Grauer, A., Crittenden, D. B., & Weycker, D. (2020). Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 31(11), 2103-2111. https://doi.org/10.1007/S00198-020-05294-3
Chiu, C. T., Lee, J. I., Lu, C. C., Huang, S. P., Chen, S. C., & Geng, J. H. (2024). The association between body mass index and osteoporosis in a Taiwanese population: a cross-sectional and longitudinal study. Scientific Reports 2024 14:1, 14(1), 1-9. https://doi.org/10.1038/s41598-024-59159-4
Fischer, V., & Haffner-Luntzer, M. (2022). Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Seminars in cell & developmental biology, 123, 14-21.
https://doi.org/10.1016/J.SEMCDB.2021.05.014
Franken Morales, S. S., Garcia Orrego, A. M., & Valenzuela Barrantes, L. (2021). Manejo de la osteoporosis en la edad posmenopáusica. Revista Medica Sinergia, 6(11), e718. https://doi.org/10.31434/rms.v6i11.718
Händel, M. N., Cardoso, I., Von Bülow, C., Rohde, J. F., Ussing, A., Nielsen, S. M., Christensen, R., Body, J. J., Brandi, M. L., Diez-Perez, A., Hadji, P., Javaid, M. K., Lems, W. F., Nogues, X., Roux, C., Minisola, S., Kurth, A., Thomas, T., Prieto-Alhambra, D., … Abrahamsen, B. (2023). Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ (Clinical research ed.), 381. https://doi.org/10.1136/BMJ-2021-068033
Hernández, A., Lanza, S., García, L., Espinal, J., Hernández, A., Lanza, S., García, L., & Espinal, J. (2023). Evaluación de la densidad mineral ósea en adultos de 40 años y más, Honduras 2022. Revista chilena de nutrición, 50(3), 271-280. https://doi.org/10.4067/S0717-75182023000300271
Leder, B. Z., Mitlak, B., Hu, M. Y., Hattersley, G., & Bockman, R. S. (2020). Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis. The Journal of clinical endocrinology and metabolism, 105(3).
https://doi.org/10.1210/CLINEM/DGZ162
Lee, J., Jung, J. H., Kim, J., Jeong, C., Ha, J., Kim, M. H., Lee, J. M., Chang, S. A., Baek, K. H., Han, K., & Lim, D. J. (2023). Associations between body composition and the risk of fracture according to bone mineral density in postmenopausal women: a population-based database cohort study. European journal of endocrinology, 189(5), 527-536. https://doi.org/10.1093/EJENDO/LVAD156
Patel, D., & Saxena, B. (2024). Decoding osteoporosis: Understanding the disease, exploring current and new therapies and emerging targets. Journal of Orthopaedic Reports, 4(4), 100472. https://doi.org/10.1016/j.jorep.2024.100472
Perez, M. O., de Alcantara Pedro, P. P., Lyrio, A. M., Grizzo, F. M. F., & da Rocha Loures, M. A. A. (2023). Osteoporosis and fracture risk assessment: improving outcomes in postmenopausal women. Revista da Associacao Medica Brasileira (1992), 69(suppl 1). https://doi.org/10.1590/1806-9282.2023S130
Ríos aij, C., Vargas, S., González, J., Vera, C., Zúñiga agh, A., Martínez agh, J., Castillo, M., Jervis, R., Salazar, R., Guevara, S., Torres, G., Uguña, F., Osvaldo Messina, D., Luis Neyro, J., Fernández, D., Maldonado, G., Intriago, M., Moreno ahi Mario Moreno Carlos Ríos A, M. A., Luis Neyro Daniel Messina, J., … Mora Alfredo Ramírez Isabela Velarde Analía Moncayo, D. H. (s. f.). ASESORES INTERNACIONALES Primer Consenso Ecuatoriano para el Manejo y Prevención de Osteoporosis COORDINADORES NACIONALES.
Shkembi, B., & Huppertz, T. (2022). Calcium absorption from food products: Food matrix effects. Nutrients, 14(1), 180. https://doi.org/10.3390/NU14010180/S1
Shoback, D., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Eastell, R. (2020). Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. The Journal of clinical endocrinology and metabolism, 105(3). https://doi.org/10.1210/CLINEM/DGAA048
Słupski, W., Jawień, P., & Nowak, B. (2021). Botanicals in Postmenopausal Osteoporosis. Nutrients, 13(5), 1609. https://doi.org/10.3390/NU13051609
Valenzuela-Martínez, S., Ramírez-Expósito, M. J., Carrera-González, M. P., & Martínez-Martos, J. M. (2023). Physiopathology of Osteoporosis: Nursing Involvement and Management. Biomedicines, 11(4), 1220. https://doi.org/10.3390/BIOMEDICINES11041220
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2024). (2024). Aging Clinical and Experimental Research, 36(S1), 174. https://doi.org/10.1007/s40520-024-02766-y
Wu, D., Cline-Smith, A., Shashkova, E., Perla, A., Katyal, A., & Aurora, R. (2021). T-Cell Mediated Inflammation in Postmenopausal Osteoporosis. Frontiers in Immunology, 12, 687551. https://doi.org/10.3389/FIMMU.2021.687551
https://doi.org/10.3390/IJMS23169465
Amin, U., McPartland, A., O’Sullivan, M., & Silke, C. (2023). An overview of the management of osteoporosis in the aging female population. Women’s health (London, England), 19.
https://doi.org/10.1177/17455057231176655
Arceo-Mendoza, R. M., & Camacho, P. M. (2021a). Postmenopausal Osteoporosis: Latest Guidelines. Endocrinology and metabolism clinics of North America, 50(2), 167-178.
https://doi.org/10.1016/J.ECL.2021.03.009
Arceo-Mendoza, R. M., & Camacho, P. M. (2021b). Postmenopausal Osteoporosis: Latest Guidelines. Endocrinology and metabolism clinics of North America, 50(2), 167-178.
https://doi.org/10.1016/J.ECL.2021.03.009
Barron, R. L., Oster, G., Grauer, A., Crittenden, D. B., & Weycker, D. (2020). Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 31(11), 2103-2111. https://doi.org/10.1007/S00198-020-05294-3
Chiu, C. T., Lee, J. I., Lu, C. C., Huang, S. P., Chen, S. C., & Geng, J. H. (2024). The association between body mass index and osteoporosis in a Taiwanese population: a cross-sectional and longitudinal study. Scientific Reports 2024 14:1, 14(1), 1-9. https://doi.org/10.1038/s41598-024-59159-4
Fischer, V., & Haffner-Luntzer, M. (2022). Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Seminars in cell & developmental biology, 123, 14-21.
https://doi.org/10.1016/J.SEMCDB.2021.05.014
Franken Morales, S. S., Garcia Orrego, A. M., & Valenzuela Barrantes, L. (2021). Manejo de la osteoporosis en la edad posmenopáusica. Revista Medica Sinergia, 6(11), e718. https://doi.org/10.31434/rms.v6i11.718
Händel, M. N., Cardoso, I., Von Bülow, C., Rohde, J. F., Ussing, A., Nielsen, S. M., Christensen, R., Body, J. J., Brandi, M. L., Diez-Perez, A., Hadji, P., Javaid, M. K., Lems, W. F., Nogues, X., Roux, C., Minisola, S., Kurth, A., Thomas, T., Prieto-Alhambra, D., … Abrahamsen, B. (2023). Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ (Clinical research ed.), 381. https://doi.org/10.1136/BMJ-2021-068033
Hernández, A., Lanza, S., García, L., Espinal, J., Hernández, A., Lanza, S., García, L., & Espinal, J. (2023). Evaluación de la densidad mineral ósea en adultos de 40 años y más, Honduras 2022. Revista chilena de nutrición, 50(3), 271-280. https://doi.org/10.4067/S0717-75182023000300271
Leder, B. Z., Mitlak, B., Hu, M. Y., Hattersley, G., & Bockman, R. S. (2020). Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis. The Journal of clinical endocrinology and metabolism, 105(3).
https://doi.org/10.1210/CLINEM/DGZ162
Lee, J., Jung, J. H., Kim, J., Jeong, C., Ha, J., Kim, M. H., Lee, J. M., Chang, S. A., Baek, K. H., Han, K., & Lim, D. J. (2023). Associations between body composition and the risk of fracture according to bone mineral density in postmenopausal women: a population-based database cohort study. European journal of endocrinology, 189(5), 527-536. https://doi.org/10.1093/EJENDO/LVAD156
Patel, D., & Saxena, B. (2024). Decoding osteoporosis: Understanding the disease, exploring current and new therapies and emerging targets. Journal of Orthopaedic Reports, 4(4), 100472. https://doi.org/10.1016/j.jorep.2024.100472
Perez, M. O., de Alcantara Pedro, P. P., Lyrio, A. M., Grizzo, F. M. F., & da Rocha Loures, M. A. A. (2023). Osteoporosis and fracture risk assessment: improving outcomes in postmenopausal women. Revista da Associacao Medica Brasileira (1992), 69(suppl 1). https://doi.org/10.1590/1806-9282.2023S130
Ríos aij, C., Vargas, S., González, J., Vera, C., Zúñiga agh, A., Martínez agh, J., Castillo, M., Jervis, R., Salazar, R., Guevara, S., Torres, G., Uguña, F., Osvaldo Messina, D., Luis Neyro, J., Fernández, D., Maldonado, G., Intriago, M., Moreno ahi Mario Moreno Carlos Ríos A, M. A., Luis Neyro Daniel Messina, J., … Mora Alfredo Ramírez Isabela Velarde Analía Moncayo, D. H. (s. f.). ASESORES INTERNACIONALES Primer Consenso Ecuatoriano para el Manejo y Prevención de Osteoporosis COORDINADORES NACIONALES.
Shkembi, B., & Huppertz, T. (2022). Calcium absorption from food products: Food matrix effects. Nutrients, 14(1), 180. https://doi.org/10.3390/NU14010180/S1
Shoback, D., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Eastell, R. (2020). Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. The Journal of clinical endocrinology and metabolism, 105(3). https://doi.org/10.1210/CLINEM/DGAA048
Słupski, W., Jawień, P., & Nowak, B. (2021). Botanicals in Postmenopausal Osteoporosis. Nutrients, 13(5), 1609. https://doi.org/10.3390/NU13051609
Valenzuela-Martínez, S., Ramírez-Expósito, M. J., Carrera-González, M. P., & Martínez-Martos, J. M. (2023). Physiopathology of Osteoporosis: Nursing Involvement and Management. Biomedicines, 11(4), 1220. https://doi.org/10.3390/BIOMEDICINES11041220
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2024). (2024). Aging Clinical and Experimental Research, 36(S1), 174. https://doi.org/10.1007/s40520-024-02766-y
Wu, D., Cline-Smith, A., Shashkova, E., Perla, A., Katyal, A., & Aurora, R. (2021). T-Cell Mediated Inflammation in Postmenopausal Osteoporosis. Frontiers in Immunology, 12, 687551. https://doi.org/10.3389/FIMMU.2021.687551
Publicado
2025-01-22
Cómo citar
Franco Diaz, O. M., Sánchez Ortega, M. C., & Agudo Gonzabay , B. M. (2025). Osteoporosis y riesgo de fracturas en mujeres posmenopáusicas. Revisión bibliográfica. Ciencia Latina Revista Científica Multidisciplinar, 8(6), 9830-9843. https://doi.org/10.37811/cl_rcm.v8i6.15647
Número
Sección
Ciencias de la Salud
Derechos de autor 2025 Odalys Mishelle Franco Diaz, Michelle Carolina Sánchez Ortega, Brigida Maritza Agudo Gonzabay
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.png)
.png)
1.png)
